Sequana Medical Investor Presentation 2024 - Fluid Overload Treatment

Sequana Medical presents its innovations in treating fluid overload across liver disease, heart failure, and cancer. The company develops the alfapump® system for refractory ascites and DSR® therapy, with regulatory approvals in Europe and ongoing clinical investigations in the US and Canada.